Actively Recruiting
Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries
Led by Zagazig University · Updated on 2025-01-14
111
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will be undertaken to compare the analgesic effects of of fentanyl versus dexmedetomidine as adjuvant to bupivacaine in combined IPACK and ACB for pain management after total knee arthroplasty.
CONDITIONS
Official Title
Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient acceptance
- Cooperative patients
- Age between 21 and 85 years old
- Both males and females
- Physical status ASA I, II, or III
- Body Mass Index (BMI) of 35 kg/m2 or less
- Undergoing elective unilateral knee surgeries (total knee arthroplasty, ACL reconstruction, or knee arthroscopy)
You will not qualify if you...
- Any contraindications to regional blocks such as coagulopathy or local infection at the injection site
- Known allergy to bupivacaine, dexmedetomidine, or fentanyl
- Advanced liver, kidney, heart, neurological, or respiratory diseases
- Chronic opioid use exceeding 3 months or daily oral morphine use above 5 mg for 1 month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
faculty of human medicine, Zagazig university hospitals
El Sharkia, Egypt
Actively Recruiting
Research Team
D
Dina Sadek Salem, MD
CONTACT
S
Sherif Mowafy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here